• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

    2.620 -0.090 (-3.32%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 700,680
    Open 2.750
    Bid (Size) 2.600 (100)
    Ask (Size) 2.630 (900)
    Prev. Close 2.710
    Today's Range 2.545 - 2.765
    52wk Range 1.580 - 6.010
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Eliminates Balance Sheet Debt Through Anson Equity Conversion
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire

    Performance

    YTD
    N/A
    N/A
    1 Month
    +15.4%
    +15.4%
    3 Month
    -21.3%
    -21.3%
    6 Month
    -22.5%
    -22.5%
    1 Year
    -12.4%
    -12.4%

    More News

    Read More
    News headline image
    More Than 1 Million Suicidal Depression Cases Per Year May Be Treated by 2030 via New Indication for Augmentation of Transcranial Magnetic Stimulation: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    FDA Submission for Abbreviated New Drug Application; $750 Million Market for Suicidal Depression Market Awaits Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
    Via Investor Brand Network
    NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for Dec. 2
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at NobleCon21
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
    Via ACCESS Newswire
    News headline image
    Three Revenue-Generating Facilities in Florida Plus Six More by Year-End in Expanding $750 Million Market Suicidal Depression Market: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 17, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Outlook For NRX Pharmaceuticals ↗
    Via Benzinga
    BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q3 2025 Financial Results and Host Conference Call on Nov. 17
    Via Investor Brand Network
    BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Reports Major Clinical and Corporate Milestones as Phase 3 Alzheimer’s Trial Advances Toward Completion
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    $750 Million Market On Track to $3.35 Billion by 2034 Has High Return Opportunity with First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health: NRXP
    Via Get News
    MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Launches HOPE Therapeutics’ One-Day TMS Protocol for Treatment-Resistant Depression in Florida
    Via Investor Brand Network
    News headline image
    HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗
    Via Benzinga

    Frequently Asked Questions

    Is NRX Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, NRX Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does NRX Pharmaceuticals, Inc. - Common Stock trade on?
    NRX Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock is NRXP on the Nasdaq Stock Market
    What is the current price of NRX Pharmaceuticals, Inc. - Common Stock?
    The current price of NRX Pharmaceuticals, Inc. - Common Stock is 2.620
    When was NRX Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of NRX Pharmaceuticals, Inc. - Common Stock was at 01/02/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.